Wanbury Limited operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Wanbury Limited with three other
companies in this sector in India:
SMS Lifesciences India Ltd
sales of 3.78 billion Indian Rupees [US$52.97 million]
Bajaj Healthcare Ltd
(3.70 billion Indian Rupees [US$51.90 million]
Fermenta Biotech Ltd
(4.05 billion Indian Rupees [US$56.73 million]
of which 96%
was Bulk Drugs/Chemicals).
Wanbury Limited reported sales of 3.91 billion Indian Rupees (US$54.87 million)
March of 2019.
increase of 4.6%
versus 2018, when the company's sales were 3.74 billion Indian Rupees.
Despite this increase, sales are still
below the level achieved in 2017, when Wanbury Limited
reported sales of 4.37 billion Indian Rupees.